Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/13/2778889/0/en/Acumen-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results-and-Business-Highlights.html

CHARLOTTESVILLE, Va., Nov. 13, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today reported financial results for the third quarter of 2023 and provided a business update.

Read more at globenewswire.com

Related news for (ABOS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.